Unknown

Dataset Information

0

Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer.


ABSTRACT: Angiogenesis is a process of generation of de-novo blood vessels from already existing vasculature. It has a crucial role in different physiological process including wound healing, embryonic development, and tumor growth. The methods by which therapeutic drugs inhibit tumor angiogenesis are termed as anti-angiogenesis cancer therapy. Developments of angiogenic inhibiting drugs have various limitations causing a barrier for successful treatment of cancer, where angiogenesis plays an important role. In this context, investigators developed novel strategies using nanotechnological approaches that have demonstrated inherent antiangiogenic properties or used for the delivery of antiangiogenic agents in a targeted manner. In this present article, we decisively highlight the recent developments of various nanoparticles (NPs) including liposomes, lipid NPs, protein NPs, polymer NPs, inorganic NPs, viral and bio-inspired NPs for potential application in antiangiogenic cancer therapy. Additionally, the clinical perspectives, challenges of nanomedicine, and future perspectives are briefly analyzed.

SUBMITTER: Mukherjee A 

PROVIDER: S-EPMC7013812 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8217312 | biostudies-literature
| S-EPMC8006526 | biostudies-literature
| S-EPMC7501589 | biostudies-literature
| S-EPMC5758769 | biostudies-literature
| S-EPMC400679 | biostudies-literature
| S-EPMC8036287 | biostudies-literature
| S-EPMC8241040 | biostudies-literature
| S-EPMC3096961 | biostudies-literature
| S-EPMC7381292 | biostudies-literature
| S-EPMC5725398 | biostudies-other